Last reviewed · How we verify
Non-Hodgkin's lymphoma
Approved treatments
- Oncovin · University of Colorado, Denver
- Solu-Cortef · Pfizer
- Vincristin · Arbeitsgemeinschaft medikamentoese Tumortherapie
- Valchlor · Recordati
Valchlor works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death. - Cortifoam · Pfizer
- Gliadel · Avet Lifesciences
Gliadel works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and grow. - Blenoxane · Bristol-Myers Squibb
Bleomycin works by binding to DNA and causing strand breaks, which ultimately leads to cell death. - Cortone
- Mabthera · Roche
- Celestone Soluspan
- Decadron · Generic (originally Merck)
- adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Vinblastin · The Lymphoma Academic Research Organisation
- prednison · Wen Zhang
- Medrol · Generic (originally Upjohn/Pfizer)
Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions. - Cortef · Generic (originally Merck/Upjohn)
- Uramustin
- Rodinolone
- Carmustin · University Hospital Freiburg
- Deltasone · Generic (originally Schering)
- Oncovin · Pfizer Inc.
- Oncovin · Pfizer Inc.
- Mabthera · Roche
Monoclonal antibody targeting CD20 on B-lymphocytes, mediating cell lysis via CDC and ADCC. - Mabthera · Roche
Mabthera works by binding to the CD20 antigen on B-lymphocytes, triggering their destruction. - Liposomal Doxorubicin · Pfizer
- Betametasone
Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system. - Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Trexall · Generic (originally Lederle Laboratories)
Antifolate that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis at high doses (oncology) and suppressing inflammation at low doses (autoimmune). - Methotrexat · Biocad
- Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- Hydroxydaunomycin · Weill Medical College of Cornell University
- prednisolon · Hannover Medical School
- Adriamycin · Johann Wolfgang Goethe University Hospital
- Methylprednisolon · Leiden University Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Non-Hodgkin's lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Non-Hodgkin's lymphoma treatment landscape brief
- Non-Hodgkin's lymphoma treatment updates RSS
Frequently asked questions about Non-Hodgkin's lymphoma
What drugs treat Non-Hodgkin's lymphoma?
Tracked treatments include Oncovin, Solu-Cortef, Vincristin, Valchlor, Cortifoam, Gliadel, Blenoxane, Cortone.
What is the treatment for Non-Hodgkin's lymphoma?
Standard treatment for Non-Hodgkin's lymphoma includes Oncovin, Solu-Cortef, Vincristin, Valchlor, Cortifoam. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Non-Hodgkin's lymphoma patent cliff · Non-Hodgkin's lymphoma CI report
- Treatment: Oncovin · University of Colorado, Denver
- Treatment: Solu-Cortef · Pfizer
- Treatment: Vincristin · Arbeitsgemeinschaft medikamentoese Tumortherapie
- Treatment: Valchlor · Recordati
- Treatment: Cortifoam · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing